My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$AZO {{ '2015-09-22T16:08:41+0000' | timeago}} • Webcast

In 4Q15, $AZO's inventory increased 9% over the same period last year, driven by increased product placement, new stores during the fiscal year & the acquisition of IMC. Inventory per location for the quarter was $610,000 vs. $582,000 last year and $629,000 last quarter. The IMC acquisition increased inventory per location by $15,000 this quarter.

User ritesh salot {{ '2017-01-24T14:22:47+0000' | timeago}}

Baba

User Robert Smith {{ '2017-01-24T13:01:54+0000' | timeago}}

$JNJ down 2% in pre-market trading. Earnings beat expectations, but sales disappointed. Johnson is cautious on its outlook. How it will perform in the future?

User Charles Elliston {{ '2017-01-23T20:14:24+0000' | timeago}}

A federal judge has upheld the DOJ’s decision to block the $AET-$HUM merger.

User Josh Allan {{ '2017-01-23T20:10:30+0000' | timeago}}

$YHOO is reporting today after market close. Nobody cares about this stock.

User RC xNair {{ '2017-01-23T13:41:30+0000' | timeago}}

Excellent results from $MCD

$JNJ {{ '2017-01-24T15:20:58+0000' | timeago}} • Webcast

$JNJ, which acquired $ABT’s subsidiary Abbott Medical Optics in Sept. 2016 for $4.325Bil, said that it would close this acquisition in 1Q17. The company has now completed approx. 75% of its $10Bil share repurchase program and expects to complete this program during 1H17.

$MMM {{ '2017-01-24T15:15:09+0000' | timeago}} • Webcast

$MMM commented that its oral care business was down slightly in 4Q16. The decline was partially from softening end user demand and continued channel contractions in the oral care business. Additionally, $MMM added that inventory reduction in the channel also added to the sluggish oral care business.

$NEOG {{ '2017-01-24T15:10:10+0000' | timeago}} • Announcement

$NEOG terminated its agreement with $SNES related to the manufacturing and marketing of a rodenticide being developed by $SNES. The two firms had worked together since 2014, prior to the time when the $SNES product was approved by the U.S. Environmental Protection Agency.

$STBA {{ '2017-01-24T15:03:13+0000' | timeago}} • Announcement

$STBA's BoD declared a quarterly cash dividend of $0.20 per share. This is an increase of 5.3% compared to dividend of $0.19 per share declared in the same period in the prior year. The annualized yield using the Jan. 23, 2017 closing price of $37.12 is $2.2%. The dividend is payable on Feb. 23, 2017 to shareholders of record on Feb. 9, 2017.

$JNJ {{ '2017-01-24T15:02:44+0000' | timeago}} • Webcast

In pharma business, $JNJ expects to file 10 new products by 2019, each with at least $1Bil of potential sales. The company plans to file an additional 40 line extensions by 2019, 10 of which have more than $500MM in potential sales. In the medical devices business, $JNJ aims to return to above market growth by 2H17.